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Summary The presence of cellular aggregates in cell suspensions derived from human solid tumours often
complicates subsequent evaluation of colony formation in primary soft agar cultures (Agrez et al., 1982b). In
the present study, performance of a conventional colony formation assay was observed to lack sufficient
sensitivity to identify growth and active chemotherapeutic agents in the majority of specimen cultures.
Modification of conventional methodologies to include filtration of cell suspensions, use of "proliferation
control" and "cytotoxicity control" cultures as well as vital staining were found to be essential for the valid
assessment of primary soft agar cultures in our laboratory. In addition, application of drugs to culture surface
in place ofculture incorporation appeared to facilitate culture performance and drug sensitivity testing.
Interest in the laboratory culture and drug
sensitivity testing of human solid tumours has been
prompted by a serious need to improve methods of
selecting chemotherapy for patients with advanced
malignant disease. Initial publications by Salmon
and colleagues at the University of Arizona
(Hamburger & Salmon, 1977a, b; Salmon et al.,
1978) concerning a "human tumour stem cell
assay" appeared to describe a technique capable of
generating therapeutically relevant information and
resulted in widespread in vitro drug screening by
scores of cancer research laboratories. Our cell
culture laboratory at the Mayo Clinic has been one
of the research groups evaluating the suitability of
this assay; to date over 4500 individual human
cancer specimens have been assessed here using
procedures similar to those described by Salmon
and colleagues (Salmon, 1980).
As our group has reported previously, most
human solid tumours disaggregated by mechanical
or enzymatic techniques and subsequently assessed
in primary soft agar culture contain mixtures of
single cells and cellular aggregates (Agrez et al.,
1982b). As a result, "colonies" subsequently
counted in soft agar colony formation assays of
human solid tumours generally appear to arise
from enlargement of the ceilular aggregates-initially
seeded rather than from true clonal expansion of
single tumour "stem" cells.
As observed in the present study, the inclusion
and persistence of such cellular aggregates in
primary soft agar cultures appear to necessitate
certain technical changes in culture and analysis
Correspondence: M.M. Lieber
Received 22 July 1983; accepted 21 October 1983.
procedures as well as the institution of several
quality control measures. Such modifications of the
conventional assay were observed to diminish
culture artifacts, to reduce the incidence of "false-
negative" drug sensitivity profiles and to provide
clearer demonstration of tumour cell growth within
primary cultures.
Materials and methods
Tumour acquisition and tissue derivation
Human solid tumour specimens and aliquots of
malignant effusions were obtained through the
Pathology Laboratory at St. Marys Hospital and
the Surgical Pathology Service at Rochester
Methodist Hospital in Rochester, Minnesota. A
total of 541 consecutive evaluable specimens were
assayed using modified techniques of culture and
analysis. Specimens were obtained from a wide
variety of sources: colon (127), lung (84), breast
(51), head and neck (47), kidney (39), ovary (28),
uterus (26), melanoma (19), sarcoma (15), liver (11),
prostate (9), brain (8), bladder (7), and other tissues
(70).
"Conventional" colonyformation assay
Methods of enzyme digestion, cell culture and
computerized image analysis have been reported
previously (Agrez et al., 1982a, b). These methods
are similar to that described by Salmon and
colleagues (1978) except that mechanical
disaggregation has been supplemented by enzymatic
digestion (Pavelic et al., 1980), culture media was
not pre-conditioned with rat splenocytes, and cells
have been subjected to "continuous" exposure of
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drugs and/or drug vehicle incorporated directly into
the cellular layer of soft agar cultures (Soehnlen et
al., 1980). A single in vitro concentration of each
chemotherapeutic agent was selected to match mean
plasma concentrations estimated to be present in
patients one hour after administration of a
maximum tolerated dose (Agrez et al., 1982a).
Colony formation in drug-treated cultures was
expressed relative to that in vehicle-treated cultures
as percent survival. Mean survival <30% of
control was used as an arbitrary criterion for an
"active drug" in vitro.
Modified colonyformation assay
A modified colony formation assay was performed
in identical fashion to that of the conventional
assay except for use of INT vital staining (Alley et
al., 1982), changes in the methods of tumour
digestion and filtration, replacement of agar by
agarose, and the institution of "proliferation
control" and "cytotoxicity control" cultures.
Tumour digestion and filtration Enclosed filters
were prepared from Nytex nylon mesh (Tetko, Inc.,
Elmsford, NY) and polypropylene filter holders
(Millipore Corporation, Bedford, MA) as follows:
circular discs (25mm diameter) of nylon mesh (48,
70, and 100 micron pore sizes) were cut with the
aid of a circular punch, mounted within filter
holders, and sterilized by ethylene oxide. Each
filtration unit was composed of one filter, the
entrance portal of which was fitted with sterile
syringe barrel, and the exit portal of which was
placed over a 15ml centrifuge tube. Following an
initial 2h incubation of minced tumour in RPMI
1640 media containing 10% foetal calf serum, 0.6%
collagenase II, and 0.002% DNase I, disaggregated
cells were filtered by gravity or minimal pressure
through one or more 100pm filtration units. Solid
matrix trapped on filter discs was resuspended in
fresh collagenase/DNase for an additional 2h.
Cells combined from both phases of enzyme
treatment were washed once and resuspended in a
small volume of fully supplemented CMRL 1066
media. Cell suspensions were filtered through a
70pm filtration unit just prior to microscopic
examination. Suspensions exhibiting cellular
aggregates >60pm were filtered one additional
time through a 48pm filtration unit prior to cell
count. Final suspensions for cell culture were
prepared only by dilution of a previously filtered
suspension. Passage of tumour suspension through
enclosed nylon mesh filtration units was useful not
only for the isolation and secondary disaggregation
of tumour fragments which were incompletely
dissociated during a primary phase of enzyme
treatment but also for the removal of large
aggregates just prior to plating cell suspension.
Soft agarose cell culture While the basal layer of
cultures was prepared with agar in the conventional
manner, the cellular (upper) layer was formulated
with 0.3% Seaplaque agarose (FMC Corp.,
Rockland, ME) in place of 0.3% agar and DEAE
Dextran. Following application of 1 ml aliquots of
cell suspension (500,000 nucleated cells) to each
culture basal layer, culture dishes were transferred
to a refrigerator (4°C) for 10min (to permit proper
gel formation), to room temperature for 10min,
and then to culture incubators. Use of agarose in
place of agar within the cellular layer of cultures
may have contributed to the diminished number of
aggregates plated at the time of culture as has been
noted in other semi-solid cell suspension systems
(Jerne et al., 1974 and Garvey et al., 1979). In
addition, the fact that lower temperature could be
utilized to maintain the fluid state of cell
suspensions containing agarose (34-37'C) rather
than agar (>40°C) also may have helped to sustain
the functional capacity ofcultured tumour cells.
Analysis of INT stained cultures Use of the
metabolizable dye, 2-(p-iodophenyl)-3-(p-nitro-
phenyl)-5-phenyl tetrazolium chloride (INT), in
conjunction with soft agar cell culture has been
described previously (Schaeffer & Friend, 1976; Bol
et al., 1977; Roberts et al., 1980; Alley et al., 1982).
Briefly, stock INT (Aldrich Chemical Co., 1-1040-6)
was prepared fresh weekly at a concentration of
1 mgml-1 distilled water. Optimal staining of
colonies was achieved by applying 1 ml of INT
solution to the surface of each culture followed by
reincubation at 37°C, 5% C02, and 100% relative
humidity for 20-24h. Cultures were examined with
the aid of an inverted stage, phase-light microscope
(Leitz Diavert equipped with reticule, Ernst Leitz
Co., Rockleigh, NJ) and scored by a computerized
image analyzer, the Omnicon Feature Analysis
System, Model II (Bausch and Lomb, Inc.,
Rochester, NY). The evaluable region of each
culture dish (35 contiguous fields [each
4.44 x 3.22mm2] equivalent to 500mm2) was
assessed on the basis of a standard colony count
program. The mean colony count (.60,pm
diameter) and standard error of the mean for each
group of cultures (6 dishes/control group and 3
dishes/drug-treated group) were computed and
tabulated by the analyzer. Selective scoring of
viable cell groups was achieved by adjustment of
the detection threshold to exclude images of non-
stained cell groups and debris. Cultures exhibiting
mean colony counts of <24 on Day 1 of
incubation were considered "acceptable" for assay.
"Significant" tumour cell growth ("colony"
enlargement) in primary culture was defined as an
increase in the 60pm colony count of .30 over
that determined on Day 1 of incubation (Agrez et
al., 1982b).SOFT AGAR TUMOUR CELL CULTURE 227
Results
Failure of conventional colony formation assay to
identify in vitro tumour cell growth and azide-
induced cytotoxicity
During an initial 5-month interval 825 consecutive
evaluable (adequate nucleated cell numbers and no
microbial contamination) malignant human tumour
specimens representing a wide variety of histologic
types were placed in primary soft agar culture
according to conventional methodology. In addition
to assessment of standard anticancer chemothera-
peutic agents, sodium azide at final concentrations
of 600 or 6,000pgml'- was employed as a
"cytotoxicity control" compound in each assay. Of
306 cultures exhibiting growth, only 49 (16%) were
sensitive (>70% inhibition of colony formation) to
sodium azide (10/82 sensitive to 600,ug NaN3 ml-';
39/204 sensitive to 6,000pg NaN3 ml-').
A previous investigation of cultures from
continuous human tumour cell lines and a limited
number of primary human tumour cultures
demonstrated that the use of a metabolizable vital
dye, INT, in conjunction with soft agar colony
formation assays permitted discrimination between
viable and non-viable groups of cells (Alley et al.,
1982). In the present evaluation INT was employed
in the analysis of replicate "proliferation control"
cultures derived from each of 135 consecutive
evaluable human tumour specimens following 1, 5,
and 10 or 1, 7, and 14 days of incubation. Elevated
colony counts were observed in most cultures
following 1 day of incubation: Counts ranged from
0 to 1031 INT-stained images with a median of 75;
only 48 cultured specimens (35.5%) exhibited
"acceptable" Day 1 colony counts and 44
specimens (33%) exhibited colony counts exceeding
100. Following 5 to 14 days' incubation only 22
specimens (16.3%) exhibited "significant" in vitro
growth. Thus, tumour cell growth, if present, was
overshadowed by a predominance of large cellular
aggregates initially plated in the majority of viable
specimens. Failure of the "conventional" colony
formation assay to identify growth and azide-
induced cytotoxicity prompted a major re-
assessment ofculture techniques.
Assessment of tumour cell growth following use of a
modified culture methodology
It occurred to us that the presence of larger tumour
cell aggregates and the apparent false-negative
chemosensitivity profiles observed during
performance of the conventional assay might in
part be overcome by modification of the
conventional culture methodology. In a subsequent
assessment of 66 consecutive evaluable specimens
using the modified procedure, 44 specimens (67%)
exhibited acceptable Day 1 counts (median=8) and
only 8 specimens (12%) exhibited colony counts
exceeding 100. During the course of 5 to 14 days'
incubation 25 specimens (37.9%) exhibited
significant increases in colony count ranging from
30 to 489 (median=90, "plating" efficiencies
ranging from 0.012 to 0.19%). Thus, coupled with
the use of agarose, multiple-stage nylon mesh
filtration resulted in a better appreciation of
tumour cell growth within many primary cultures.
Detection of chemosensitivity by the modified colony
formation assay
For a given specimen, drug sensitivity was assessed
shortly following exhibition of significant growth in
"proliferation control" cultures. In an initial
assessment of 72 consecutive evaluable specimens
using the modified colony formation assay 32
specimens (44%) exhibiting significant growth were
successfully assayed. Sensitivity to sodium azide
(600jgml-1) was observed in 23 specimens by
image analysis of INT-stained cultures, but in only
4 specimens by analysis of non-stained cultures.
While sensitivity to one or more chemotherapeutic
agents was observed in 19 specimens by image
analysis of INT-stained cultures, image analysis of
non-stained cultures (conventional) identified
activity in only 8 specimens (Table T). Drug
sensitivity (>70% inhibition of colony formation)
was observed on 57 individual occasions utilizing
the INT stain methodology (>90% inhibition was
noted for 33), whereas analysis of non-stained
cultures indicated drug sensitivity on only 25
individual occasions (>90% inhibition was noted
for 2). When 12 additional specimen cultures were
evaluated only by conventional image analysis due
to inadequate numbers of INT-stained colonies,
none of these cultures exhibited sensitivity to drugs
or sodium azide. (The fact that several of the azide
insensitive specimens were sensitive to one or more
chemotherapeutic agents suggest that sodium azide
may not be effectively cytotoxic in all primary
human tumour cultures.)
In a subsequent assessment 123 consecutive
evaluable specimens, 50 specimens (41%) exhibited
significant in vitro growth (data not shown). Of
these specimens, 36 exhibited sensitivity to one or
more drugs by INT analysis, whereas only 7 of the
specimens exhibited sensitivity by conventional
image analysis. For all of the cultures evaluated by
both methods to date with one exception (culture
number 3229, Table T), INT analysis resulted in the
detection of at least all agents identified by
conventional image analysis.
Of the 195 (total) consecutive evaluable tumour
specimens cultured using the new method, 82 (42%)228 M.C. ALLEY & M.M. LIEBER
Table I Sensitivity of primary human tumour cell cultures to sodium azide and
chemotherapeutic agentsa
Conventional image Image analysisfollowing
analysis INT treatment
Number Number of Number of
Tumour source ofdrugs Sodium azide "effective" Sodium azide "effective"
(culture number) assayed sensitivity drugs sensitivity drugs
Ovary (3166) 13 + 4 + 5
Lung (3167) 10 1 + 3
Rectum (3173) 9 +
Colon (3184) 3
Larynx (3185) 11 + 2
Endometrium (3186) 10 +
Breast (3187) 7
Rectum (3190) 1 1
Breast (3194) 15 1 + 4
Ovary (3196B) 1 +
Kidney (3199) 20 + 3
Colon (3209) 20 + I
Breast (3215) 3
Ovary (3218) 6 +
Melanoma (3219) 17 + 3 + 3
Breast (3221) 4 +
Lung (3225) 18 2 + 6
Ovary (3229) 13 5 4
Kidney (3231) 1
Colon (3234) 3 + 2
Breast (3237) 3 + I
Neck (3240) 11 + 3 + 7
Ovary (3242) 18 7 + 7
Colon (3246) 7 +
Endometrium (3247) 18 + I
Colon (3252) 6 3
Endometrium (3253) 7 1
Ovary (3255) 19 +
Ovary (3258) 8 +
Lung (3264) 11 + 1
Thyroid (3269) 11
Gastroesophagus (3270) 10 + + 2
aSodium azide sensitivity as well as drug "efficacy"
refers to . 70% inhibition ofcolony formation.
exhibited in vitro growth. While drug sensitivity was
observed for 55 specimens (28%) utilizing INT
stain, analysis of non-stained cultures indicated
drug sensitivity for only 15 specimens (7.7%). Thus,
the detection of growth and chemosensitivity of
tumour cells cultured and analyzed according to the
modified methodology was better than that
observed using our previous methodology. Despite
multi-step filtration of tumour cell suspensions in
order to eliminate plating of large cellular
aggregates, the majority of cultures still required
the use of vital staining for the identification of
active chemotherapeutic agents.
Microscopic profile of stained and non-stained cell
groups in primary tumour cultures
Microscopic inspection of cultures provided a
useful means to examine the disparities between
conventional image analysis and image analysis
following INT treatment. Cultures exhibiting
growth contained many densely-stained cell groups
with diameters >60 m (Figure la). By contrast,
inspection of effectively drug-treated cultures often
revealed proportionately fewer groups of cells and
an overall lack of stain in cell groups less than as
well as greater than 60pm in diameter (Figure lb).SOFT AGAR TUMOUR CELL CULTURE 229
b
Figure 1 Photomicrographs of a typical soft agarose cell culture following 9 days' incubation (INT stain).
Many cell groups within control cultures (a) exceed 60 m in diameter and exhibit densely-stained central
regions as well as peripheral processes. By comparison, few cell groups within effectively drug-inhibited
cultures (b) exceed 60pm in diameter and very few are fully stained.
At low magnification such non-stained cell groups
appeared to possess typical morphology of
"'colonies". Despite evidence of regional
deterioration at higher magnification the overall
morphology of a given cell group appeared
"intact", perhaps due to physical stabilization
provided by the surrounding culture matrix. That
cell groups lacking INT stain are non-viable has
been confirmed by application of other supravital
stains (i.e., trypan blue and acridine
orange/ethidium bromide) to the same culture
and/or replicate cultures. The presence of drugs in
culture at concentrations employed for routine
screening does not appear to alter INT metabolism
by viable tumour cell line cultures (Alley et al.,
1982).
Microscopic observations coupled with the fact
that substantial increases in colony count and size
occur between 1 and 5 days' incubation in drug-
treated cultures suggests that doomed tumour cells
can undergo significant growth before cytostasis
and cytotoxicity imposed by drugs becomes
manifest. Discrimination between viable and non-
viable cell groups is particularly important in the
assessment of primary tumour cell cultures because
the number of viable cell groups is exceeded often
greatly by the total non-viable cellularity and debris
present in culture at the time of analysis. For this
reason, use of INT (or perhaps other vital stains)
appears to be mandatory for valid detection of
growth as well as identification of effective chemo-
therapeutic agents.
Alternate method of drug application in the chemo-
sensitivity testing ofprimary tumour cell cultures
Another aspect of conventional culture
methodology which affects culture performance is
the method for exposing cells to drugs. The usual
protocol requires that prior to setting up bilayer
cultures, aliquots of cell suspension be transferred
to separate tubes, each containing a different drug,
the same drug at different concentrations, and/or
respective drug vehicles followed by the addition of
several media supplements (Soehnlen et al., 1980).
After mixing the contents of each tube, aliquots of
cell suspension are applied to replicate culture
dishes using a different pipet for each tube. Each
step not only imposes a degree of technical
difficulty, but also reduces the accuracy of
dispensing the same number of cells into each
culture dish.
As an alternate approach for drug exposure, we
assessed the potential utility of setting up all
cultures from a single, large volume of cell
suspension followed by the application of drug
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Figure 2 A comparison of drug activities in primary human tumour cell culture following two methods of
drug application. The graph depicts paired mean % survival data gathered from nine individual specimen
cultures (see text). N=sodium azide (600pgml-1); F=5-fluorouracil (10pgml-1); M=mitomycin C
(0.04pgml-1); A=actinomycin D (0.0 pgml-1); D=doxorubicin (0.6Mgml-1); V=vinblastine (0.05 pg ml-1);
P=cisplatin (1.5gmml -1).
directly to soft agarose culture surfaces. Preliminary
experiments demonstrated that agarose matrix
provides no significant barrier to the diffusion of
any of 24 standard chemotherapeutic agents.
Application of 100p1 of concentrated drug solution
(final culture concentration, pgml- 1)* to
continuous human tumour cell line cultures
containing ml base layer and 1 ml cellular layer
resulted in .70% inhibition of colony formation
(.90% inhibition in most cases) by all agents not
requiring metabolic activation.
*actinomycin D (0.010), bisantrene (0.50), doxorubicin
(0.60), L-alanosine (50), acridinyl anisidide (1.0), cytosine
arabinoside (0.20), AZQ (1.0), carmustine (2.0), bleomycin
(2.0), dibromodulcitol (5.0), galactitol (2.0), 5-fluorouracil
(10), mitoguazone (50), chlorozotocin (2.0), hydroxyurea
(60), methotrexate (1.0), mitomycin C (0.040), PALA
(200), cisplatin (1.5), streptozotocin (6.0), triazinate (40),
vinblastine (0.050), teniposide (10), etoposide (10).
In a subsequent experiment, drug activity
following application by the incorporation
technique was compared with that following
application by the overlay technique for 7 agents in
9 primary human tumour cell cultures (2 colon, 4
kidney, and 3 ovary). Linear regression analysis of
paired data is shown in Figure 2. All entries except
3 (circled) fall within 95% confidence limits of the
line Y=0.914 X+22.1, where X represents the
percent survival resulting from the drug overlay
technique and Y represents the percent survival
measured by the drug incorporation technique
(r=0.780, n =42, P<0.001). A slope factor of 0.914
(±0.234, 95% CI) coupled with a Y intercept of
22.1 (± 13.0, 95% CI) suggests the drug overlay
technique provides a somewhat more sensitive
measure of drug effects overall.
The drug overlay technique was employed in the
assessment of 145 consecutive evaluable human
solid tumour specimens. Significant growth was
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observed in 73 specimen cultures, 50 of which were
sensitive to sodium azide and 55 of which were
sensitive to one or more chemotherapeutic agents.
As shown in Table II, use of the drug overlay
technique in this recent series of tumour cultures
resulted in similar if not higher frequencies of
detecting growth and chemosensitivity than were
observed for the drug incorporation method in an
earlier series of specimen cultures. While similar
frequencies of azide and drug sensitivity were
observed for the two methodologies when data is
expressed relative to the number of assays (A), the
fact that a higher incidence of growth occurred
following drug overlay appears to have resulted in
an overall higher frequency of chemosensitivity
detection relative to the number of cultures (C).
The diminished proliferation capacity of cells
cultured by the drug incorporation technique may
be due to the excessive mechanical manipulation of
cells at elevated temperature required by that
technique.
Table II Evaluability and chemosensitivity of primary
human tumour cultures following two methods of drug
applicationI' b
Drug Drug
Criteria incorporation overlay
Consecutive evaluable
specimen cultures (C): 195 145
Cultures exhibiting
significant growth
and successfully
assayed (A): 82 76
(42.1% of C) (52.4% of C)
Azide sensitive: 57 50
(69.5% ofA; (65.8% of A;
29.2% of C) 34.5% of C)
Drug sensitive: 55 55
(67% ofA; (72.4% ofA;
28.2% of C) 37.9% of C)
Azide and/or drug
sensitive: 71 63
(86.6% ofA; (82.9% ofA;
36.4% of C) 43.4% of C)
aData from two separate phases of study are
summarized (see text). Table entries indicate the number
and normalized frequencies of specimen cultures meeting
each criterion.
bSensitivity refers to . 70% inhibition of colony
formation by sodium azide (600 ugml-1) or
chemotherapeutic agents present at clinically achievable
concentrations.
The observation that sodium azide was not
highly cytotoxic in -30% of the specimen cultures
assayed prompted us to investigate the possible
utility of other cytotoxic control agents. Of 50
consecutively assayed specimen cultures, all were
sensitive (>95% inhibition of "colony" formation
in all but 2 specimen cultures) to mercuric chloride
(100pgml-1, final culture concentration), whereas
only 34 (68%) were azide-sensitive (>70%
inhibition). These data indicate that mercuric
chloride is a highly effective "cytotoxicity control"
agent.
Discussion
Five years following the first publication concerning
drug sensitivity testing in primary human tumour
cell cultures by Salmon and colleagues (1978),
critical assessments of the "human tumour stem cell
assay" have begun to appear in the literature. Some
have presented "theoretical" considerations of
"stem cell" biology, whereas others have discussed
the relevance of in vitro drug sensitivity to the
clinical management of patients (e.g., Selby et al.,
1983; Editorial, 1983). Our perspective concerning
the "human tumour stem cell assay" has been more
pragmatic and constructively critical: that of a
laboratory investigating whether it is possible to
correct numerous technical problems with its
conventional performance. The present manuscript
describes method modifications and specific
"control" measures which we feel are essential for
valid detection of growth and drug sensitivity
determinations of cultured human solid tumour
cells.
A key observation at a practical level (as well as
possibly theoretical "stem cell" level) is the nearly
universal presence of aggregated cells in culture
suspensions prepared by either enzymatic or
mechanical disaggregation techniques. As a
consequence, many "colonies" observed following
one to two weeks' culture incubation arise from the
enlargement ofpre-existing cell aggregates (Agrez et
al., 1982b). Because of the initial presence of such
cell aggregates in soft agar matrix, a valid assay
must "account" for them. First, a major effort
must be made to eliminate large cellular aggregates
(>60pm diameter) from tumour cell suspensions.
In the present study, a series of filtrations
accomplished this goal without imposing significant
reductions in tumour cell yield. Second, appropriate
"proliferation control" cultures must be evaluated
the day after the cultures are initiated in order to
determine the size and number of cellular
aggregates which are invariably present.
Computerized image analysis of INT-stained
cultures permits objective achievement of this task.
(It is important to note that cell groups in non-
stained cultures often exhibit minimal optical
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therefore, are inefficiently detected by computerized
image analysis.) Third, soft agar colony formation
assays utilized for drug screening of necessity must
include one or more "cytotoxicity control"
compounds (e.g., sodium azide or mercuric
chloride). "Cytotoxicity control" cultures in
conjunction with vital staining must demonstrate
>90% inhibition of colony formation before a
given assay can be considered valid for drug
screening. Finally, since cellular aggregates which
undergo spontaneous or drug-induced death persist
in soft agar culture, we believe that use of INT
which provides a means to distinguish viable groups
ofcells from non-viable cell groups and debris from
detection (Alley et al., 1982) markedly improves
optical determinations of growth and drug
sensitivity in this assay.
Previous studies utilizing the "human tumour
stem cell assay" have employed either "one hour"
exposure of tumour cells to drugs prior to culture
or "continuous" exposure to drugs incorporated
within the soft agar culture matrix (Soehnlen et al.,
1980). The alternate method of drug exposure
assessed in the present study, culture surface
application, appears to be far less cumbersome.
Also, such a technique eliminates the possibility
that a "mechanical" feature of the drug application
itself could contribute to the failure of cell growth.
None of the published reports which suggest a
possible role for the "human tumour stem cell
assay" in clinical selection of anticancer therapy has
acknowledged the series of technical problems
described herein. We, as others, believe these
reports should be viewed with an attitude of
"cautious skepticism" (Rupniak & Hill, 1980;
Bertoncello et al., 1980; Lieber & Kovach, 1982)
Editorial, 1982. The incorporation of aggregated
cells into culture as well as the persistence of non-
viable cell groups and debris in soft agar matrix
undoubtedly contribute to false-negative in vitro
drug sensitivity profiles. Indeed, most previously
reported in vitro experiments utilizing the
conventional "human tumour stem cell assay" to
test drugs failed to identify significant in vitro drug
sensitivity. Since commonly tested human tumours
(colon, breast, renal, melanoma, etc.) are clinically
resistant to most single agent therapies and since
the majority of contributions to "positive"
correlation have been between in vitro drug
resistance and clinical resistance, it is not surprising
to us that excellent in vitro/in vivo correlations have
been reported thus far.
Whether the assessment of short-term in vitro
growth by tumour cells exposed to anticancer drugs
will prove to be clinically useful remains to be
determined by prospective laboratory and
laboratory/clinic correlative studies. At present it is
clear that multiple technical problems are
associated with conventional performance of the
"human tumour stem cell assay". Nevertheless,
specific modifications of this assay coupled with
appropriate "control" measures appear to improve
detection of in vitro tumour cell growth and drug
sensitivity.
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